Dishman Pharmaceuticals and Chemicals Limited
Dishman Pharmaceuticals and Chemicals Limited, commonly referred to as Dishman, is a prominent player in the pharmaceutical and chemical industry, headquartered in India. Established in 1983, the company has made significant strides in the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and contract research services, catering to a global clientele. With major operational regions across Europe, North America, and Asia, Dishman is renowned for its innovative approach to custom synthesis and its commitment to quality. The company’s core offerings include a diverse range of APIs and specialty chemicals, distinguished by their adherence to stringent regulatory standards and a focus on sustainability. Dishman’s market position is bolstered by its state-of-the-art facilities and a strong emphasis on research and development, making it a trusted partner in the pharmaceutical sector.
DitchCarbon Score
How does Dishman Pharmaceuticals and Chemicals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dishman Pharmaceuticals and Chemicals Limited's score of 4 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dishman Pharmaceuticals and Chemicals Limited's reported carbon emissions
Dishman Pharmaceuticals and Chemicals Limited, headquartered in India, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. In the absence of detailed emissions data, it is important to note that Dishman Pharmaceuticals has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi). Furthermore, there are no documented climate pledges or initiatives aimed at reducing their carbon footprint. As the pharmaceutical and chemicals industry increasingly focuses on sustainability, Dishman Pharmaceuticals may need to consider establishing clear climate commitments and reduction strategies to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dishman Pharmaceuticals and Chemicals Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
